These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 15350467)
21. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Mai G; Nguyen TH; Morel P; Mei J; Andres A; Bosco D; Baertschiger R; Toso C; Berney T; Majno P; Mentha G; Trono D; Buhler LH Xenotransplantation; 2005 Nov; 12(6):457-64. PubMed ID: 16202069 [TBL] [Abstract][Full Text] [Related]
22. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver. Poyck PP; Hoekstra R; van Wijk AC; Attanasio C; Calise F; Chamuleau RA; van Gulik TM Liver Transpl; 2007 Apr; 13(4):589-98. PubMed ID: 17394165 [TBL] [Abstract][Full Text] [Related]
23. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs. Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934 [TBL] [Abstract][Full Text] [Related]
24. Potentiality of immobilized pig hepatocyte spheroids in bioartificial liver system. Lee JH; Lee DH; Park JK; Kim SK; Kwon CH; Lee SK Transplant Proc; 2012 May; 44(4):1012-4. PubMed ID: 22564612 [TBL] [Abstract][Full Text] [Related]
25. Modulation of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) gene expression in isolated porcine hepatocytes perfused within a radial-flow bioreactor after low-temperature storing. Mischiati C; Puviani AC; Brogli M; Guarniero S; Sereni A; Breda L; Ricci D; Galavotti D; Morsiani E; Gambari R Int J Artif Organs; 2003 Feb; 26(2):139-48. PubMed ID: 12653348 [TBL] [Abstract][Full Text] [Related]
26. A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. De Bartolo L; Jarosch-Von Schweder G; Haverich A; Bader A Biotechnol Prog; 2000; 16(1):102-8. PubMed ID: 10662497 [TBL] [Abstract][Full Text] [Related]
27. [Use of normal human hepatocytes in a hybrid organ system]. Auth MK; Okamoto M; Ichida Y; Auth SH; Gerlach J; Encke A; McMaster P; Strain AJ Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):665-8. PubMed ID: 14518338 [TBL] [Abstract][Full Text] [Related]
28. Isolation and short term cultivation of swine hepatocytes for bioartificial liver support system. Li J; Li LJ; Chao HC; Yang Q; Liu XL; Sheng JF; Yu HY; Huang JR Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):249-53. PubMed ID: 15908324 [TBL] [Abstract][Full Text] [Related]
31. Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. Cho CH; Park J; Nagrath D; Tilles AW; Berthiaume F; Toner M; Yarmush ML Biotechnol Bioeng; 2007 May; 97(1):188-99. PubMed ID: 17054120 [TBL] [Abstract][Full Text] [Related]
32. Construction and performance of a minibioreactor suitable as experimental bioartificial liver. Rodriguez JV; Pizarro MD; Scandizzi AL; Guibert EE; Almada LL; Mamprin ME Artif Organs; 2008 Apr; 32(4):323-8. PubMed ID: 18370948 [TBL] [Abstract][Full Text] [Related]
33. Characterization of a hollow fiber bioartificial liver device. Abu-Absi SF; Seth G; Narayanan RA; Groehler K; Lai P; Anderson ML; Sielaff T; Hu WS Artif Organs; 2005 May; 29(5):419-22. PubMed ID: 15854219 [TBL] [Abstract][Full Text] [Related]
34. Metabolic effects of a novel bioartificial liver on serum from severe hepatitis patients: an in vitro study. Yan F; Zhao J; Ma J; Li Z; Su Q Chin Med J (Engl); 2003 Oct; 116(10):1471-4. PubMed ID: 14570603 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of Nafamostat Mesilate for improving the performance of a bioartificial liver using porcine hepatocytes. Fujioka H; Eguchi S; Sugiyama N; Kawazoe Y; Kawashita Y; Kamohara Y; Azuma T; Furui J; Kanematsu T Int J Artif Organs; 1999 Jul; 22(7):505-10. PubMed ID: 10493559 [TBL] [Abstract][Full Text] [Related]
36. [Isolation and culture of pig hepatocyte in large scale for the application of bioartificial liver system]. Chung YJ; Lee HJ; Koh YT; Kim SB; Kim SH; Choi SH; Yi NJ; Chang SH; Yang EL; Suh KS; Lee YS; Lee KU Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):249-55. PubMed ID: 12499781 [TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of cross-circulation system using semipermeable membrane combined with whole liver perfusion. Umehara M; Totsuka E; Ishizawa Y; Nara M; Hakamada K; Sasaki M Transplant Proc; 2004 Oct; 36(8):2349-51. PubMed ID: 15561245 [TBL] [Abstract][Full Text] [Related]
39. In vitro morphological and functional characterization of isolated porcine hepatocytes for extracorporeal liver support: bile acid uptake and conjugation. Morsiani E; Pazzi P; Moscioni AD; Rozga J; Azzena G; Demetriou AA J Surg Res; 1998 Sep; 79(1):54-60. PubMed ID: 9735240 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. Poyck PP; van Wijk AC; van der Hoeven TV; de Waart DR; Chamuleau RA; van Gulik TM; Oude Elferink RP; Hoekstra R J Hepatol; 2008 Feb; 48(2):266-75. PubMed ID: 18093687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]